GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cantel Medical Corp (NYSE:CMD) » Definitions » Operating Income

Cantel Medical (Cantel Medical) Operating Income : $131 Mil (TTM As of Apr. 2021)


View and export this data going back to 1992. Start your Free Trial

What is Cantel Medical Operating Income?

Cantel Medical's Operating Income for the three months ended in Apr. 2021 was $46 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Apr. 2021 was $131 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Cantel Medical's Operating Income for the three months ended in Apr. 2021 was $46 Mil. Cantel Medical's Revenue for the three months ended in Apr. 2021 was $314 Mil. Therefore, Cantel Medical's Operating Margin % for the quarter that ended in Apr. 2021 was 14.50%.

Warning Sign:

Cantel Medical Corp operating margin has been in 5-year decline. The average rate of decline per year is -18%.

Cantel Medical's 5-Year average Growth Rate for Operating Margin % was -18.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cantel Medical's annualized ROC % for the quarter that ended in Apr. 2021 was 7.41%. Cantel Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2021 was 41.97%.


Cantel Medical Operating Income Historical Data

The historical data trend for Cantel Medical's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantel Medical Operating Income Chart

Cantel Medical Annual Data
Trend Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.25 110.41 121.66 83.52 48.31

Cantel Medical Quarterly Data
Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.44 3.84 50.35 31.63 45.52

Cantel Medical Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Apr. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $131 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantel Medical  (NYSE:CMD) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cantel Medical's annualized ROC % for the quarter that ended in Apr. 2021 is calculated as:

ROC % (Q: Apr. 2021 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2021 ) + Invested Capital (Q: Apr. 2021 ))/ count )
=182.096 * ( 1 - 31.16% )/( (1690.136 + 1691.335)/ 2 )
=125.3548864/1690.7355
=7.41 %

where

Invested Capital(Q: Jan. 2021 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2050.31 - 117.113 - ( 243.061 - max(0, 234.547 - 638.04+243.061))
=1690.136

Invested Capital(Q: Apr. 2021 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2031.278 - 121.415 - ( 218.528 - max(0, 242.954 - 625.997+218.528))
=1691.335

Note: The Operating Income data used here is four times the quarterly (Apr. 2021) data.

2. Joel Greenblatt's definition of Return on Capital:

Cantel Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2021 is calculated as:

ROC (Joel Greenblatt) %(Q: Apr. 2021 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jan. 2021  Q: Apr. 2021
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=182.096/( ( (276.158 + max(149.941, 0)) + (276.568 + max(165.046, 0)) )/ 2 )
=182.096/( ( 426.099 + 441.614 )/ 2 )
=182.096/433.8565
=41.97 %

where Working Capital is:

Working Capital(Q: Jan. 2021 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(159.372 + 170.075 + 22.388) - (117.113 + 29.908 + 54.873)
=149.941

Working Capital(Q: Apr. 2021 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(164.929 + 179.078 + 23.911) - (121.415 + 30.903 + 50.554)
=165.046

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Apr. 2021) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Cantel Medical's Operating Margin % for the quarter that ended in Apr. 2021 is calculated as:

Operating Margin %=Operating Income (Q: Apr. 2021 )/Revenue (Q: Apr. 2021 )
=45.524/313.953
=14.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Cantel Medical Operating Income Related Terms

Thank you for viewing the detailed overview of Cantel Medical's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantel Medical (Cantel Medical) Business Description

Traded in Other Exchanges
N/A
Address
150 Clove Road, 9th Floor, Little Falls, NJ, USA, 07424
Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.
Executives
Ann E Berman director 255 STATE STREET, BOSTON MA 02109
Jeffrey Z Mann officer: SVP, General Counsel 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
George L Fotiades director, officer: Chief Executive Officer 281 SUMMIT AVENUE, SUMMIT NJ 07901
Charles M Diker director, 10 percent owner, officer: Chairman ONE NEW YORK PLAZA, NEW YORK NY 10004
Shaun M. Blakeman officer: SVP - CFO C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Jean Casner officer: SVP and CHRO 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Brian Capone officer: SVP and Princ. Accounting Ofr 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Peter G Clifford officer: President and COO 40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047
Seth M Yellin officer: Executive Vice President 150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424
Laura L Forese director 849 STONEWALL COURT FRANKLIN LAKES NJ 07417
Peter Pronovost director JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231
Anthony B Evnin director C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Ronnie Myers director TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595
Alan R Batkin director 399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022
Karen Prange director 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316